Search Results - "Long, Jessica B."

Incidence of Heart Failure or Cardiomyopathy After Adjuvant Trastuzumab Therapy for Breast Cancer by Chen, Jersey, MD, MPH, Long, Jessica B., MPH, Hurria, Arti, MD, Owusu, Cynthia, MD, MS, Steingart, Richard M., MD, Gross, Cary P., MD

“…Objectives The purpose of this study was to estimate heart failure (HF) and cardiomyopathy (CM) rates after adjuvant trastuzumab therapy and chemotherapy in a…”
Get full text

Risk Prediction Model for Heart Failure and Cardiomyopathy After Adjuvant Trastuzumab Therapy for Breast Cancer by Ezaz, Ghideon, Long, Jessica B., Gross, Cary P., Chen, Jersey

“…Background Adjuvant trastuzumab improves survival for women with human epidermal growth factor receptor 2‐positive breast cancer, but increases risk for heart…”
Get full text

Assessing the Impact of a Cooperative Group Trial on Breast Cancer Care in the Medicare Population by SOULOS, Pamela R, YU, James B, ROBERTS, Kenneth B, RALDOW, Ann C, HERRIN, Jeph, LONG, Jessica B, GROSS, Cary P

“…The Cancer and Leukemia Group B (CALGB) C9343 trial found that adjuvant radiation therapy (RT) provided minimal benefits for older women with breast cancer…”
Get full text

Genetic testing in privately insured women with surgically treated breast cancer by Dinan, Michaela A., Pitafi, Sarah, Greenup, Rachel A., Long, Jessica B., Gross, Cary P.

“…Purpose Rates of BRCA1 and BRCA2 prevalence among women with breast cancer vary by age, hormone receptor status, and family history. Recommendations for…”
Get full text

Treatment patterns and real-world effectiveness of rituximab maintenance in older patients with mantle cell lymphoma: a population-based analysis by Di, Mengyang, Long, Jessica B, Kothari, Shalin K, Sethi, Tarsheen, Zeidan, Amer M, Podoltsev, Nikolai A, Shallis, Rory M, Wang, Rong, Ma, Xiaomei, Huntington, Scott F

Get full text

Patterns of Use and Short-Term Complications of Breast Brachytherapy in the National Medicare Population From 2008–2009 by PRESLEY, Carolyn J, SOULOS, Pamela R, HERRIN, Jeph, ROBERTS, Kenneth B, YU, James B, KILLELEA, Brigid, LESNIKOSKI, Beth-Ann, LONG, Jessica B, GROSS, Cary P

“…Brachytherapy has disseminated into clinical practice as an alternative to whole-breast irradiation (WBI) for early-stage breast cancer; however, current…”
Get full text

The role of lung cancer risk and comorbidity in lung cancer screening use by Richman, Ilana B., Long, Jessica B., Poghosyan, Hermine, Sather, Polly, Gross, Cary P.

“…Although lung cancer screening (LCS) with low dose computed tomography has been shown to reduce lung cancer mortality, benefits and harms of screening vary…”
Get full text

The Adoption of New Adjuvant Radiation Therapy Modalities Among Medicare Beneficiaries With Breast Cancer: Clinical Correlates and Cost Implications by Roberts, Kenneth B., MD, Soulos, Pamela R., MPH, Herrin, Jeph, PhD, Yu, James B., MD, Long, Jessica B., MPH, Dostaler, Edward, BA, Gross, Cary P., MD

“…Purpose New radiation therapy modalities have broadened treatment options for older women with breast cancer, but it is unclear how clinical factors,…”
Get full text

Risk of myeloid neoplasms after radiotherapy among older women with localized breast cancer: A population-based study by Zeidan, Amer M, Long, Jessica B, Wang, Rong, Hu, Xin, Yu, James B, Huntington, Scott F, Abel, Gregory A, Mougalian, Sarah S, Podoltsev, Nikolai A, Gore, Steven D, Gross, Cary P, Ma, Xiaomei, Davidoff, Amy J

“…There are inconsistent and limited data regarding the risk of myeloid neoplasms (MN) among breast cancer survivors who received radiotherapy (RT) in the…”
Get full text

Estimating Breast Cancer Overdiagnosis After Screening Mammography Among Older Women in the United States by Richman, Ilana B, Long, Jessica B, Soulos, Pamela R, Wang, Shi-Yi, Gross, Cary P

“…Overdiagnosis is increasingly recognized as a harm of breast cancer screening, particularly for older women. To estimate overdiagnosis associated with breast…”
Get full text

Trends in Breast Cancer Screening Costs Among Privately Insured Women Aged 40 to 64 Years by Richman, Ilana B, Long, Jessica B, Kunst, Natalia, Kyanko, Kelly, Xu, Xiao, Busch, Susan, Gross, Cary P

Get more information

Comparative clinical effectiveness of azacitidine versus decitabine in older patients with myelodysplastic syndromes by Zeidan, Amer M., Davidoff, Amy J., Long, Jessica B., Hu, Xin, Wang, Rong, Ma, Xiaomei, Gross, Cary P., Abel, Gregory A., Huntington, Scott F., Podoltsev, Nikolai A., Hajime, Uno, Prebet, Thomas, Gore, Steven D.

“…Summary The hypomethylating agents (HMAs) azacitidine and decitabine are both approved for treatment of myelodysplastic syndromes (MDS) in the USA. In Europe,…”
Get full text

Associations Between Sentinel Lymph Node Biopsy and Complications for Patients with Ductal Carcinoma In Situ by Killelea, Brigid K., Long, Jessica B., Dang, Weixiong, Mougalian, Sarah S., Evans, Suzanne B., Gross, Cary P., Wang, Shi-Yi

“…Purpose To examine the associations between sentinel lymph node biopsy (SLNB) and complications among older patients who underwent breast-conserving surgery…”
Get full text

Use and Costs of Breast Cancer Screening for Women in Their 40s in a US Population With Private Insurance by Kunst, Natalia, Long, Jessica B, Xu, Xiao, Busch, Susan H, Kyanko, Kelly A, Richman, Ilana B, Gross, Cary P

Get more information

Trends in use of intensive care during hospitalizations at the end-of-life among older adults with advanced cancer by Jain, Snigdha, Long, Jessica B, Rao, Vinay, Law, Anica C, Walkey, Allan J, Prsic, Elizabeth, Lindenauer, Peter K, Krumholz, Harlan M, Gross, Cary P

“…High-intensity end-of-life (EOL) care, marked by admission to intensive care units (ICUs) or in-hospital death, can be costly and burdensome. Recent trends in…”
Get full text

Use of surveillance mammography among older patients with a history of breast cancer by Berger, Elizabeth, Long, Jessica B., Sheffrin, Meera, Lindsay, Meghan, Richman, Ilana B.

Get full text

Comparative Effectiveness of Digital Breast Tomosynthesis for Breast Cancer Screening Among Women 40-64 Years Old by Richman, Ilana B, Long, Jessica B, Hoag, Jessica R, Upneja, Akhil, Hooley, Regina, Xu, Xiao, Kunst, Natalia, Aminawung, Jenerius A, Kyanko, Kelly A, Busch, Susan H, Gross, Cary P

“…Digital breast tomosynthesis (DBT) may have a higher cancer detection rate and lower recall compared with 2-dimensional (2 D) mammography for breast cancer…”
Get full text

Risk of Vascular Toxicity with Platinum Based Chemotherapy in Elderly Patients with Bladder Cancer by Gupta, Amit, Long, Jessica B, Chen, Jersey, Gross, Cary P, Feldman, Darren R, Steingart, Richard M

“…Purpose Platinum based chemotherapy is widely used for bladder cancer but is associated with vascular toxicity, especially thromboembolism. We evaluated the…”
Get full text

Preoperative Breast Magnetic Resonance Imaging and Contralateral Breast Cancer Occurrence Among Older Women With Breast Cancer by Wang, Shi-Yi, Long, Jessica B, Killelea, Brigid K, Evans, Suzanne B, Roberts, Kenneth B, Silber, Andrea, Gross, Cary P

“…Preoperative magnetic resonance imaging (MRI) detects occult contralateral breast cancers (CBCs) in women with breast cancer, but the impact of detection on…”
Get full text

Understanding Regional Variation in the Cost of Breast Cancer Screening Among Privately Insured Women in the United States by Kunst, Natalia, Long, Jessica B., Xu, Xiao, Busch, Susan H., Kyanko, Kelly A., Lindau, Stacy T., Richman, Ilana B., Gross, Cary P.

“…Breast cancer screening for women aged 40-49 years is prevalent and costly, with costs varying substantially across US regions. Newer approaches to mammography…”
Get full text